Archive: August 16 – 23, 2010

Join the Division of Nephrology as we present our monthly Grand Rounds lecture series. This month’s featured topic is:

Understanding Hyponatremia: Treating Beyond the Primary Diagnosis (Long)

by

Biff Palmer, MD
Director, Nephrology Fellowship Program
University of Texas Southwestern Medical Center

Nephrology On-Demand will be providing a summary of the Grand Rounds and discussion. In addition, prerequisite reading material is provided by clicking here. We welcome your contributions to this interesting topic through the Comments section.

**Note: Only registered users can view the Summary and contribute to the online discussion. Click here if you wish to register.**

Nephrology On-Demand is calling on all users who are interested in blogging on Nephrology-related topics. Bloggers can be physicians, nurses, dietitians, patients, etc. and must have the following skills:

- Access to email
- Note taking skills
- An interest in sharing medical information with the Nephrology On-Demand community

We are accepting the following types of blogs:

- standard text blogs
- audio blogs
- video blogs

If you have an interest in blogging and are planning to attend a conference, seminar, workshop, mini-review, or other formal course/class, please contact the Editor-in-Chief by clicking here.

Note: Knowledge of computer or web programming is absolutely not required. Nephrology On-Demand will provide complimentary IT resources to users who wish to blog.

Questions

Across

• 1. The acronym for the condition that occurs in up to 50% of stem cell transplant recipients
• 2. The drug class of choice in the treatment of thrombotic microangiopathy
• 3. True or False: There are more stem cell transplants performed each year than kidney transplants
• 4. Chronic graft-versus-host disease is associated with this nephrologic syndrome
• 5. Severe forms of thrombotic microangiopathy require this form of therapy
• 6. The type of stem cell transplant whereby the transplanted cells are from the patient

Down

• 7. an antithrombotic and fibrinolytic used in the management of venoocclusive disease
• 8. This entity is indistinguishable from hepatorenal syndrome and is a major cause of renal failure in patients undergoing myeloablative stem cell transplantation
• 9. The type of stem cell transplant whereby the cells are from a donor

Top Times

• No Times Recorded Yet

Keep your eyes on Nephrology On-Demand for more information on the following meetings:

NKF Spring Clinical Meeting 2011 — Abstract Deadline December 3, 2010
North American Society for Dialysis and Transplantation 2010 — Abstract Deadline May 28, 2010
Southern Society for Clinical Investigation 2011 — Abstract deadline expected to be October 2010
ACP Medical Student Abstract Competition 2011 — deadline expected to be early-December 2010
ACP Resident and Fellows Abstract Competition 2011 — expected deadline not yet announced; check back in August 2010 for more information
ISN Abstract Competition 2011 — expected deadline not yet announced
American Transplant Congress 2011 — expected to be open in September 2010
International Society of Blood Purification — Abstract Deadline July August 30, 2010
Evidence 2010 — Abstract Deadline August 6, 2010